Occult Primary Panel - Disclosures
|
Panel Member
|
John Abad MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Omar Abughanimeh MBBS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Salwan Al Mutar MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Bajor MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Bowles MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sam Brondfield MD, MA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Julie Bykowski MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Andrew Coveler MD |
|
Grant/Research Support
|
| Actuate | Amgen Inc. | AstraZeneca Pharmaceuticals LP | BeiGene | Kyowa Hakko Kirin Co., Ltd. | Mirati | Nextrast | Novocure | Nucana | Pfizer Inc. |
|
Date Completed
|
03/18/2025 |
|
Panel Member
|
Harry Fuentes Bayne MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
David Gierada MD |
|
Equity Interest/Stock Options
|
| Kenvue, Inc. |
|
Grant/Research Support
|
| Delfi Diagnostics |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
G. Weldon Gilcrease MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Danielle Guyette PsyD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joyce Habib MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Zachary Kohutek MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Christina Kong MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jeremy Kortmansky MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Kosteva MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Emily Kovach BS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anuradha Krishnamurthy MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Richard Lee MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Renato Lenzi MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ming-Tseh Lin MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sam Lubner MD, FACP |
|
Equity Interest/Stock Options
|
| Elephas Bio |
|
Date Completed
|
04/15/2025 |
|
Panel Member
|
Megan Lyons MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicholas McAndrew MD, MSCE |
|
Grant/Research Support
|
| Arvin's | Daiichi- Sankyo Co. | Dizal | Eisai Inc. | Loco | Novartis Pharmaceuticals Corporation | SeaGen |
|
Date Completed
|
07/31/2024 |
|
Panel Member
|
Mateusz Opyrchal MD, PhD |
|
Grant/Research Support
|
| ALPHAGENERON PHARMACEUTICALS | ERGOMED LLC | IDEAYA BIOSCIENCES | IQVIA | KRYSTAL BIOTECH | MEDPACE LLC | PPD INVESTIGATOR SERVICES LLC | SYNEOS HEALTH | WEREWOLF THERAPEUTICS INC | WORLDWIDE CLINICAL TRIALS, INC |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Darryl Outlaw MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sharon Park PharmD, BCOP |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Anuj Patel MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
John Phay MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Asif Rashid MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kerry Reynolds MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Stephen Rosenberg MD, MS |
|
Grant/Research Support
|
| Merck & Co., Inc. |
|
Date Completed
|
03/06/2025 |
|
Panel Member
|
Leonard Saltz MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Namrata Setia MD |
|
Product/Speakers Bureau
|
| Astellas Pharma US, Inc. |
|
Date Completed
|
01/06/2025 |
|
Panel Member
|
Jeffrey Smerage MD, PhD |
|
Grant/Research Support
|
| AstraZeneca Pharmaceuticals LP |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Ian Solsky MD, MPH |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marvaretta Stevenson MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bettyanne Sunderland BSN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Siao-Yi Wang MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
